Xiaoxing Wang1, Amanda Hefton1, Kathryn Ni1, Kennedy C Ukadike1, Michael A Bowen2, Mary Eckert3, Anne Stevens4, Christian Lood1, Tomas Mustelin5. 1. X. Wang, PhD, A. Hefton, K. Ni, BS, K.C. Ukadike, MD, Acting Instructor, C. Lood, PhD, Associate Professor, T. Mustelin, MD, PhD, Professor, Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington. 2. M.A. Bowen, PhD, Product and Process Development, Allogene Therapeutics, San Francisco, California. 3. M. Eckert, BS, Seattle Children's Research Institute, Seattle, Washington. 4. A. Stevens, MD, Professor, Seattle Children's Research Institute, Seattle, Division of Rheumatology, Department of Pediatrics, University of Washington, Seattle, Washington, and Janssen Research & Development, LLC, Wayne, Pennsylvania, USA. 5. X. Wang, PhD, A. Hefton, K. Ni, BS, K.C. Ukadike, MD, Acting Instructor, C. Lood, PhD, Associate Professor, T. Mustelin, MD, PhD, Professor, Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington; tomas2@uw.edu.
Abstract
OBJECTIVE: Autoantibodies against proteins encoded by human endogenous retrovirus K (HERV-K) have been reported in patients with rheumatoid arthritis (RA), but their relevance, if any, has remained unresolved. We revisited this question and tested if such autoantibodies may react with citrullinated epitopes on the envelope (Env) protein of HERV-K. METHODS: Immunoblotting and ELISAs were conducted with unmodified Env protein and with Env citrullinated by protein arginine deiminase 4 (PAD4). Sera from 100 patients with RA, plasma from 32 patients with juvenile idiopathic arthritis (JIA), and healthy adult and pediatric controls were included. Antibody reactivity was evaluated for correlations with clinical and laboratory variables of the patients. RESULTS: We replicated and expanded upon published data suggesting that patients with RA or JIA have autoantibodies against HERV-K Env, some with high titers. Anti-HERV-K antibodies correlated with cigarette smoking and with circulating myeloperoxidase-DNA complexes indicative of nonapoptotic neutrophil cell death. Further, most of the patients with RA, but not those with JIA, had autoantibodies that reacted more strongly with Env that was citrullinated by PAD4. These anticitrullinated Env autoantibodies correlated with seropositivity and tended to be higher in patients with erosive disease. CONCLUSION: Our data suggest that anti-HERV-K immunity is elevated in RA and JIA and may have a connection with pathogenic protein citrullination in RA.
OBJECTIVE: Autoantibodies against proteins encoded by human endogenous retrovirus K (HERV-K) have been reported in patients with rheumatoid arthritis (RA), but their relevance, if any, has remained unresolved. We revisited this question and tested if such autoantibodies may react with citrullinated epitopes on the envelope (Env) protein of HERV-K. METHODS: Immunoblotting and ELISAs were conducted with unmodified Env protein and with Env citrullinated by protein arginine deiminase 4 (PAD4). Sera from 100 patients with RA, plasma from 32 patients with juvenile idiopathic arthritis (JIA), and healthy adult and pediatric controls were included. Antibody reactivity was evaluated for correlations with clinical and laboratory variables of the patients. RESULTS: We replicated and expanded upon published data suggesting that patients with RA or JIA have autoantibodies against HERV-K Env, some with high titers. Anti-HERV-K antibodies correlated with cigarette smoking and with circulating myeloperoxidase-DNA complexes indicative of nonapoptotic neutrophil cell death. Further, most of the patients with RA, but not those with JIA, had autoantibodies that reacted more strongly with Env that was citrullinated by PAD4. These anticitrullinated Env autoantibodies correlated with seropositivity and tended to be higher in patients with erosive disease. CONCLUSION: Our data suggest that anti-HERV-K immunity is elevated in RA and JIA and may have a connection with pathogenic protein citrullination in RA.
Authors: Bhargavi Duvvuri; Lauren M Pachman; Gabrielle Morgan; Amer M Khojah; Marisa Klein-Gitelman; Megan L Curran; Stephen Doty; Christian Lood Journal: Arthritis Rheumatol Date: 2020-01-01 Impact factor: 10.995
Authors: Edward J Grow; Ryan A Flynn; Shawn L Chavez; Nicholas L Bayless; Mark Wossidlo; Daniel J Wesche; Lance Martin; Carol B Ware; Catherine A Blish; Howard Y Chang; Renee A Reijo Pera; Joanna Wysocka Journal: Nature Date: 2015-04-20 Impact factor: 49.962
Authors: Henri-Alexandre Michaud; Miguel de Mulder; Devi SenGupta; Steven G Deeks; Jeffrey N Martin; Christopher D Pilcher; Frederick M Hecht; Jonah B Sacha; Douglas F Nixon Journal: Retrovirology Date: 2014-01-28 Impact factor: 4.602
Authors: Reinout Raijmakers; Joyce J B C van Beers; Mahmoud El-Azzouny; Natasja F C Visser; Borut Božič; Ger J M Pruijn; Albert J R Heck Journal: Arthritis Res Ther Date: 2012-05-14 Impact factor: 5.156